This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

CADE queries rivals in AmBev's planned acquisition of Brasil Kirin's beverage plant in Rio de Janeiro state

By Ana Paula Candil ( April 15, 2016, 16:49 GMT | Insight) -- Brazilian antitrust officials have asked beer producers Cervejaria Petrópolis and Heineken whether they were offered the opportunity to buy a beverage plant in Rio de Janeiro state that Brasil Kirin intends to sell to AmBev. Brasil Kirin and Ambev have notified the antitrust agency of their deal using the full-form notification, although they say that their market shares won’t change after the transaction.Brazilian antitrust officials have asked beer producers Cervejaria Petrópolis and Heineken whether they were offered the opportunity to buy a beverage plant in Rio de Janeiro state that Brasil Kirin intends to sell to AmBev. Brasil Kirin and Ambev have notified the antitrust agency of their deal using the full-form notification, although they say that their market shares won’t change after the transaction....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login